In summary, rational design has led to the development of two long-acting GLP-1 analogs, liraglutide and semaglutide, that have made a vast contribution to the management of T2D in terms of improvements in glycemic control, body weight, blood pressure, lipids, beta-cell function, and CV outcomes
Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux en Y gastric bypass
Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry
Because tirzepatide engages two incretin pathways, it is technically distinct from single-receptor GLP-1 receptor agonists, even though it is commonly discussed alongside them
synthetic melanin, can cause nausea, vomiting, flushing, stomach cramps, decreased appetite, fatigue and allergic reactions, and can even accelerate the onset of skin cancers